BURRELL INTERNATIONAL GROUP LLC

Lobbying for AMO PHARMA, LTD. · Biopharmaceutical research and development

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Rare Disease Policy and FDA Policy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.